Viking Therapeutics shares are trading lower after the company announced the pricing of its public offering of 6,471,000 common shares at $85 per share.
Portfolio Pulse from Benzinga Newsdesk
Viking Therapeutics announced the pricing of its public offering of 6,471,000 common shares at $85 per share, leading to a decrease in its stock price.
February 29, 2024 | 4:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Viking Therapeutics' stock price is trading lower following the announcement of its public offering of 6,471,000 common shares at $85 per share.
Public offerings often lead to a decrease in stock price due to the dilution of existing shares. Viking Therapeutics' announcement of a significant public offering at $85 per share has likely contributed to a decrease in its stock price as investors adjust to the increased share count and potential dilution.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100